About 14 results found for searched term "CDK-IN-2" (0.054 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M13601 | CDK9-IN-2 | CDK |
| CDK9-IN-2 is a special cyclin-dependent kinase 9 (CDK9) inhibitor, with IC50s of 5 nM and 7 nM in H929 multiple myeloma(MM) cell line (72 hours) and A2058 skin cell line (72 hours), respectively. | ||
| M29353 | CDK1-IN-2 | CDK |
| CDK1-IN-2 is a CDK1 inhibitor (IC50: 5.8 μM). | ||
| M31196 | CDK12-IN-2 | CDK |
| CDK12-IN-2 is a potent, selective and nanomolar CDK12 inhibitor (IC50=52 nM). CDK12-IN-2 is also a strong CDK13 inhibitor due to CDK13 is the closest homologue of CDK12. CDK12-IN-2 inhibits the phosphorylation of Ser2 in the C-terminal domain of RNA polymerase II. CDK12-IN-2 can be used an excellent chemical probe for functional studies of CDK12. | ||
| M31199 | CDK-IN-2 | CDK |
| CDK-IN-2 is a potent and specific CDK9 inhibitor with IC50 of <8 nM. | ||
| M41425 | CDK7-IN-25 | CDK |
| CDK7-IN-25 (CY-16-1) is a CDK-7 inhibitor (IC50<1nM) that can be used in cancer research. | ||
| M41431 | CDK4-IN-2 | CDK |
| CDK4-IN-2 is a CDK4 inhibitor, with Ki and IC50 values of <10 nM. | ||
| M41435 | CDK9-IN-23 | CDK |
| CDK9-IN-23 is a CDK9 inhibitor with an IC50 of <20 nM. | ||
| M41439 | CDK7-IN-22 | CDK |
| CDK7-IN-22 is an CDK7 inhibitor with antitumor activity. | ||
| M41441 | CDK9-IN-27 | CDK |
| CDK9-IN-27 is a CDK9 inhibitor (IC50s: 0.424 μM). | ||
| M41442 | CDK9-IN-26 | CDK |
| CDK9-IN-26 is a CDK9 inhibitor (IC50=0.18 μM). | ||
| M41443 | CDK-IN-12 | CDK |
| CDK-IN-12 is a CDK Inhibitor. | ||
| M41444 | CDK7-IN-21 | CDK |
| CDK7-IN-21 is a potent CDK7 inhibitor. | ||
| M49512 | CDK7-IN-20 | CDK |
| CDK7-IN-20 is a potent, selective and irreversible CDK7 (CDK) inhibitor with an IC50 value of 4 nM. | ||
| M49513 | CDK8-IN-12 | CDK |
| CDK8-IN-12 is an orally active, potent CDK8 inhibitor with a Ki of 14 nM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
